What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients

Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination

(2016) Sudarshini Ramanathan et al.   AUTOIMMUNITY REVIEWS

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

(2016) Sven Jarius et al.   Journal of Neuroinflammation

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin

(2016) Sven Jarius et al.   Journal of Neuroinflammation

The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates

(2016) Shahd HM Hamid et al.   Multiple Sclerosis Journal

Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder

(2016) Jae-Won Hyun et al.   NEUROLOGY

The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates

(2016) Shahd HM Hamid et al.   Multiple Sclerosis Journal

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

(2014) Romana Höftberger et al.   Multiple Sclerosis Journal

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

(2014) D. K. Sato et al.   NEUROLOGY

Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays

(2012) P. J. Waters et al.   NEUROLOGY